VANCOUVER-The locally headquartered vaccine maker ID Biomedical Corporation has inked sale-leaseback agreements with life science REIT Alexandria Real Estate Equities for two of its facilities. Pasadena, CA-based Alexandria will pay $40.8 million for R&D facilities totaling 128,000 sf in Laval, Quebec and Northborough, MA. In return, ID Biomedical will lease them back for 15 years, not including three five-year extension options. The companies expect to close the transactions by the end of January.A source at ID Biomedical tells GlobeSt.com the assets involved in the transaction came with the company’s $120-million purchase of the vaccine business of Basingstoke, UK-based Shire Pharmaceuticals Group plc. That transaction closed in September. ID Biomedical has no plans to “monetize” any other real estate assets at this time, according to the company source.The facility in Laval contains 68,000 sf of floor area and the facility in Northborough contains 60,000 sf of floor area, according to the source. ID president Todd Patrick says the transactions will give the company access to additional capital to invest in its R&D and commercial programs. “Securing long-term leases allows us to continue to pursue our business activities as normal …,” he said.ID Biomedical has a leading position in the Canadian influenza market. The company supplies about 75% of the Canadian government’s influenza vaccine purchases. In addition, it received a 10-year mandate from the Government of Canada in 2001 to assure a state of readiness in the case of an influenza pandemic such that it can provide influenza vaccine for all Canadians in such an event. Alexandria develops, owns and manages properties designed and improved for lease primarily to pharmaceutical, biotechnology, life science product, service, biodefense, educational and translational medicine institutions and entities, as well as related government agencies. Alexandria currently owns and operates 112 properties comprising approximately 7.4 million sf.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

GlobeSt

Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2024 ALM Global, LLC. All Rights Reserved.